Fluorous Affinity Capping for Oligonucleotide Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing and purifying oligonucleotides face challenges with low yields and impurities due to the instability of capping groups under deprotection conditions, especially for longer oligomers, and the inefficiency of traditional purification techniques like reversed-phase chromatography and trityl-on purification.
Innovation Solution
The use of phosphorous-based fluorous affinity capping reagents that cap failure sequences, allowing for high-yield and high-purity purification of oligonucleotides through fluorous affinity chromatography, even for long oligomers, by selectively retaining capped sequences on fluorous supports.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional capping reagents (acetic anhydride or phosphite monoester) are used to cap failure sequences, then the capping reaction can be performed, but the capping groups are labile to deprotection conditions resulting in poor purification or low yields
Solution Approach 1:
The patent changes the chemical nature of the capping group from traditional acyl or trityl groups to perfluoroalkyl groups. This parameter change in chemical composition provides superior stability under deprotection conditions while maintaining effectiveness in preventing chain elongation, thereby resolving the contradiction between reliability and productivity
Solution Approach 2:
The invention uses a composite approach by combining the capping function with a fluorous affinity tag (perfluoroalkyl group). This composite structure serves dual purposes: capping the failure sequence and enabling subsequent fluorous affinity purification, which improves both stability and purification efficiency
2Manufacturing precision
If reversed-phase chromatography or trityl-on purification is used, then purification can be performed, but the hydrophobic interactions are not strong enough and isolation efficiency decreases rapidly with increasing chain length
Solution Approach 1:
The patent changes the purification mechanism from hydrophobic interactions to fluorous affinity interactions. This parameter change in the interaction type provides stronger and more consistent binding that does not deteriorate with increasing oligonucleotide chain length, resolving the contradiction between manufacturing precision and chain length
Solution Approach 2:
The perfluoroalkyl capping group acts as an intermediary that provides a strong affinity handle for fluorous affinity chromatography. This intermediary enables efficient separation based on the fluorous-fluorous interaction, which is not affected by the length of the oligonucleotide chain, thus improving purification efficiency for long oligomers
3Ease of manufacture
If acyl or trityl capping groups are used, then failure sequences can be capped, but the groups are relatively labile to synthesis conditions resulting in poor purification
Solution Approach 1:
The patent changes the chemical composition of the capping group to perfluoroalkyl, which has superior stability characteristics. This parameter change maintains ease of manufacture through efficient coupling reactions while dramatically improving stability under both synthesis and deprotection conditions, resolving the contradiction between ease of manufacture and reliability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the efficient separation of full-length oligonucleotides from failure sequences, achieving high yields and purities, even for oligomers greater than 15mers, by leveraging the strong affinity of fluorous groups for perfluoroalkyl compounds.
Implementation Method 1
separating the non-capped oligomers of desired target sequence from capped oligomers by fluorous affinity chromatography
Data Source
Figure 1
Figure 2~3b
Figure 4
AI summary
The present invention provides methods of extending nucleic acids and purifying target nucleic acids. The methods include the use of capping reagents to effect chain termination and provide a handle for purification via fluorous affinity methods.